Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris

American Heart Journal
J B SchwartzD C Harrison

Abstract

The long-term efficacy of once-daily atenolol cardioselective beta-blockade therapy for chronic stable angina pectoris was studied in nine coronary disease patients. After a placebo-controlled single-blind dose-ranging trial with 2-week drug periods of 25, 50, 100, and 200 mg, they continued on 100 or 200 mg daily for 1 year. Treadmill exercise test (ET) were performed at times at peak and trough serum atenolol concentrations and 24-hour ECG ambulatory recordings were obtained after placebo, after 2 weeks of 100 and 200 mg atenolol, and after 2 weeks of 100 and 200 mg atenolol, and after 3, 6, 9, and 12 months of 100 or 200 mg atenolol. During early and chronic atenolol therapy, angina frequency and nitroglycerin consumption were decreased (p less than 0.01 to less than 0.001). Twenty-four hour ECG and ET showed sustained heart rate suppression. Exercise duration until angina onset was prolonged during all periods of atenolol administration. Maximal improvement in exercise tolerance and angina relief was not reached until 3 months of atenolol therapy despite stable serum drug concentrations. During the 14 months fatigue occurred in three patients which was dose-limiting in only one. Thus atenolol 100 or 200 mg given once daily,...Continue Reading

References

Aug 21, 1976·British Medical Journal·J S Vilsvik, J Schaanning
Jan 1, 1976·Clinical Pharmacokinetics·G Johnsson, C G Regàrdh
Sep 27, 1979·The New England Journal of Medicine·J Koch-Weser
Nov 8, 1979·The New England Journal of Medicine·F H Meyers
May 17, 1978·European Journal of Clinical Pharmacology·J D FitzgeraldJ McAinsh
Nov 1, 1969·Archives of Internal Medicine·H J ZeftE S Orgain
Mar 1, 1980·Circulation·G JacksonD C Harrison

❮ Previous
Next ❯

Citations

Jan 1, 1990·European Journal of Clinical Pharmacology·P FitschaB Tiso
Apr 12, 1984·The New England Journal of Medicine·J DeanfieldK Fox
Jul 1, 1993·International Journal of Cardiology·R SteffensenS Haunsø
Apr 26, 2006·The American Journal of Cardiology·Donald Carey Harrison
Oct 11, 2005·European Heart Journal·Jean-Claude TardifUNKNOWN INITIATIVE Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.